TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% |
| Q3 2021 | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% |
| Q2 2021 | $582,000 | -19.5% | 15,000 | 0.0% | 0.35% | -18.9% |
| Q1 2021 | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% |
| Q4 2020 | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
| Q3 2020 | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
| Q2 2020 | $292,000 | +97.3% | 15,000 | 0.0% | 0.18% | +34.4% |
| Q1 2020 | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% |
| Q4 2019 | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% |
| Q3 2019 | $84,000 | -35.4% | 15,000 | 0.0% | 0.06% | -29.1% |
| Q2 2019 | $130,000 | +7.4% | 15,000 | 0.0% | 0.08% | +3.9% |
| Q1 2019 | $121,000 | +95.2% | 15,000 | 0.0% | 0.08% | +28.8% |
| Q4 2018 | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% |
| Q3 2018 | $84,000 | -57.4% | 15,000 | 0.0% | 0.05% | -59.7% |
| Q2 2018 | $197,000 | – | 15,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 5,229,619 | $74,261,000 | 3.55% |
| RA Capital Management | 2,472,344 | $35,107,000 | 2.69% |
| SENZAR ASSET MANAGEMENT, LLC | 475,918 | $6,758,000 | 2.13% |
| BRIDGER MANAGEMENT, LLC | 2,373,920 | $33,710,000 | 2.04% |
| Opaleye Management Inc. | 274,200 | $3,893,000 | 1.11% |
| Virtus ETF Advisers LLC | 89,920 | $1,277,000 | 1.11% |
| Eversept Partners, LP | 150,000 | $2,130,000 | 0.99% |
| Ghost Tree Capital, LLC | 300,000 | $4,260,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $710,000 | 0.42% |
| HIGHLAND CAPITAL MANAGEMENT LP | 464,391 | $6,595,000 | 0.34% |